| Rapid reconfiguration of the functional connectome after chemogenetic locus coeruleus activation V Zerbi, A Floriou-Servou, M Markicevic, Y Vermeiren, O Sturman, ... Neuron 103 (4), 702-718. e5, 2019 | 246 | 2019 |
| Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease E Gerrits, N Brouwer, SM Kooistra, ME Woodbury, Y Vermeiren, ... Acta neuropathologica 141, 681-696, 2021 | 201 | 2021 |
| Targeting the norepinephrinergic system in Parkinson's disease and related disorders: the locus coeruleus story Y Vermeiren, PP De Deyn Neurochemistry international 102, 22-32, 2017 | 114 | 2017 |
| Age‐and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease FJH Sorgdrager, Y Vermeiren, M Van Faassen, C Van Der Ley, ... Journal of Neurochemistry 151 (5), 656-668, 2019 | 102 | 2019 |
| Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease S Van der Mussele, K Bekelaar, N Le Bastard, Y Vermeiren, J Saerens, ... International Journal of Geriatric Psychiatry 28 (9), 947-958, 2013 | 101 | 2013 |
| Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease? AD Dekker, A Strydom, AMW Coppus, D Nizetic, Y Vermeiren, ... Cortex 73, 36-61, 2015 | 95 | 2015 |
| Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease Y Vermeiren, D Van Dam, T Aerts, S Engelborghs, PP De Deyn Neurobiology of aging 35 (12), 2691-2700, 2014 | 89 | 2014 |
| Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults S Van der Mussele, N Le Bastard, Y Vermeiren, J Saerens, N Somers, ... International journal of geriatric psychiatry 28 (3), 265-275, 2013 | 77 | 2013 |
| Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease Y Vermeiren, D Van Dam, T Aerts, S Engelborghs, PP De Deyn Journal of Alzheimer's Disease 41 (3), 819-833, 2014 | 74 | 2014 |
| Neuropsychiatric disturbances in Alzheimer’s disease: what have we learned from neuropathological studies? DV Dam, Y Vermeiren, A D Dekker, P JW Naudé, P P De Deyn Current Alzheimer Research 13 (10), 1145-1164, 2016 | 67 | 2016 |
| The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease Y Vermeiren, D Van Dam, T Aerts, S Engelborghs, JJ Martin, PP De Deyn Alzheimer's research & therapy 7, 1-18, 2015 | 60 | 2015 |
| Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia Y Vermeiren, N Le Bastard, A Van Hemelrijck, WH Drinkenburg, ... Alzheimer's & Dementia 9 (5), 488-498, 2013 | 58 | 2013 |
| The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer’s disease: A narrative review E Aaldijk, Y Vermeiren Ageing Research Reviews 75, 101556, 2022 | 57 | 2022 |
| The behavioral and psychological symptoms of dementia in down syndrome (BPSD-DS) scale: comprehensive assessment of psychopathology in down syndrome AD Dekker, S Sacco, A Carfi, B Benejam, Y Vermeiren, G Beugelsdijk, ... Journal of Alzheimer's Disease 63 (2), 797-819, 2018 | 56 | 2018 |
| A complete pupillometry toolbox for real-time monitoring of locus coeruleus activity in rodents M Privitera, KD Ferrari, LM von Ziegler, O Sturman, SN Duss, ... Nature protocols 15 (8), 2301-2320, 2020 | 51 | 2020 |
| Neutrophil gelatinase-associated lipocalin and its receptors in Alzheimer’s disease (AD) brain regions: differential findings in AD with and without depression DW Dekens, PJW Naudé, S Engelborghs, Y Vermeiren, D Van Dam, ... Journal of Alzheimer's Disease 55 (2), 763-776, 2017 | 46 | 2017 |
| Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome AD Dekker, AMW Coppus, Y Vermeiren, T Aerts, CM Van Duijn, ... Journal of Alzheimer's Disease 43 (3), 871-891, 2015 | 46 | 2015 |
| Novel and sensitive reversed-phase high-pressure liquid chromatography method with electrochemical detection for the simultaneous and fast determination of eight biogenic … D Van Dam, Y Vermeiren, T Aerts, PP De Deyn Journal of chromatography A 1353, 28-39, 2014 | 45 | 2014 |
| Brain serotonergic and noradrenergic deficiencies in behavioral variant frontotemporal dementia compared to early-onset Alzheimer’s disease Y Vermeiren, J Janssens, T Aerts, JJ Martin, A Sieben, D Van Dam, ... Journal of Alzheimer's Disease 53 (3), 1079-1096, 2016 | 44 | 2016 |
| Serotonergic dysfunction in amyotrophic lateral sclerosis and Parkinson's disease: similar mechanisms, dissimilar outcomes Y Vermeiren, J Janssens, D Van Dam, PP De Deyn Frontiers in Neuroscience 12, 343712, 2018 | 34 | 2018 |
